Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS

NCT06098118 | Completed

• 1 other identifier: STUDY00032987
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

This community-engaged research project will test an adapted online breast cancer screening decision aid to address the needs of women living in an area where environmental contamination has increased concern about breast cancer risk. It will provide novel data on individual experiences with breast cancer risk assessment and decisional determinants of screening choices in a community disproportionately impacted by industrial pollution.

Conditions

Breast Cancer Screening

Keywords

per- and polyfluoroalkyl substances; breast cancer screening; decision aid; risk assessment

Outcome Measures

Primary Outcomes (1)

• Acceptability

  Acceptability e-scale,72 a 6-item measure for electronically-delivered interventions

  Within 1 day, post-intervention

Secondary Outcomes (4)

• Knowledge

  Immediately pre-intervention, within 1 day post-intervention

• Decisional Conflict

  Immediately pre-intervention, within 1 day post-intervention

• Screening self-efficacy

  Immediately pre-intervention, within 1 day post-intervention

• Screening Intentions

  Immediately pre-intervention, within 1 day post-intervention

Study Arms (1)

Decision Aid

EXPERIMENTAL

Participants will receive the adapted MyMammogram decision aid that includes environmental risk information.

Behavioral: MyMammogram decision aid

Interventions

MyMammogram decision aid BEHAVIORAL

An online breast cancer screening decision aid that includes personalized risk assessment, information on benefits and risks of mammography screening, values clarification, outcome expectancies, and a summative document with participant responses.

Decision Aid

Eligibility Criteria

• Age: 39 Years - 49 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Females aged 39-49
• No personal history of breast cancer,
• No mammogram in the prior 12 months
• Resident of Merrimack, Hillsborough, Rockingham or Bennington counties

You may not qualify if:

• History of breast cancer, ductal carcinoma in situ, lobular carcinoma in situ
• Cognitive impairment impeding the ability to provide informed consent

Sponsors & Collaborators

• Trustees of Dartmouth College: lead

Study Sites (1)

Dartmouth College

Hanover, New Hampshire, 03755, United States

Location

Related Publications (1)

• St Angelo M, Romano ME, Gallagher L, Gunn CM. Supporting informed decisions about breast cancer screening in communities with known environmental contamination: a pre-post study. Cancer Causes Control. 2025 Dec 27;37(1):11. doi: 10.1007/s10552-025-02100-5.

  PMID: 41455034 DERIVED

MeSH Terms

Conditions

Progressive Encephalomyelitis with Rigidity

Study Officials

• Christine M Gunn, PhD

  Dartmouth College, Geisel School of Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: October 13, 2023
• First Posted: October 24, 2023
• Study Start: May 6, 2024
• Primary Completion: December 23, 2024
• Study Completion: December 23, 2024
• Last Updated: January 8, 2025

Record last verified: 2025-01

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
• Time Frame: Data will be available after primary paper is published and for up to 3 years.

Locations

US (1)